Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2

被引:25
|
作者
Itoh, T
Itagaki, S
Sumi, Y
Hirano, T
Takemoto, I
Iseki, K
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Therapeut, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Sapporo Social Insurance Gen Hosp, Dept Pharm, Atsubetsu Ku, Sapporo, Hokkaido 0048618, Japan
关键词
irinotecan; diarrhea; Caco-2; cells; baicalin;
D O I
10.1007/s00280-004-0937-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to investigate the transport mechanisms of transporters that contribute to the intestinal uptake of 7-ethyl-10-hydroxycamptothecin (SN-38). Methods: Human intestinal epithelial Caco-2 cells were used to investigate the mechanistic basis of transepithelial uptake of SN-38. We investigated the characteristics of SN-38 uptake into Caco-2 cells. The effects of baicalin and sulfobromophthalein (BSP) on the uptake of SN-38 by Caco-2 cells were examined. Results: Uptake of SN-38 was significantly reduced at 4 degrees C. Baicalin inhibited the uptake of SN-38 in a concentration-dependent manner. BSP significantly reduced the uptake of SN-38. However, probenecid, pravastatin and grepafloxacin did not affect the uptake of SN-38. Conclusions: The results suggest that a specific transport system mediates the uptake of SN-38 across the apical membrane in Caco-2 cells.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 50 条
  • [1] Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2
    Tatsuya Itoh
    Shirou Itagaki
    Yoshinobu Sumi
    Takeshi Hirano
    Isao Takemoto
    Ken Iseki
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 420 - 424
  • [2] Involvement of Specific Transport System on Uptake of Lactone Form of SN-38 in Human Intestinal Epithelial Cell Line Caco-2
    Ueno, Yusuke
    Matsuda, Hiroko
    Mizutani, Hideki
    Iwamoto, Takuya
    Okuda, Masahiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (01) : 54 - 58
  • [3] Effect of bile acids on the uptake of irinotecan and its active metabolite, SN-38, by intestinal cells
    Kobayashi, K
    Ceryak, S
    Matsuzaki, Y
    Kudoh, S
    Bouscarel, B
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2001, 1525 (1-2): : 125 - 129
  • [4] pH-dependent uptake of irinotecan and its active metabolite, SN-38, by intestinal cells
    Kobayashi, K
    Bouscarel, B
    Matsuzaki, Y
    Ceryak, S
    Kudoh, S
    Fromm, H
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (04) : 491 - 496
  • [5] Secretory transport of irinotecan metabolite SN-38 across isolated intestinal tissue
    Shirou Itagaki
    Yoshinobu Sumi
    Soji Shimamoto
    Tatsuya Itoh
    Takeshi Hirano
    Isao Takemoto
    Ken Iseki
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 502 - 506
  • [6] Secretory transport of irinotecan metabolite SN-38 across isolated intestinal tissue
    Itagaki, S
    Sumi, Y
    Shimamoto, S
    Itoh, T
    Hirano, T
    Takemoto, I
    Iseki, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (05) : 502 - 506
  • [7] Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats
    Yamamoto, Michiko
    Kurita, Akinobu
    Asahara, Takashi
    Takakura, Akira
    Katono, Ken
    Iwasaki, Maiko
    Ryuge, Shinichiro
    Wada, Mayuko
    Onoda, Sayaka
    Yanaihara, Tomoko
    Yokoba, Masanori
    Mitsufuji, Hisasht
    Nishji, Yasuto
    Fukui, Tomoya
    Masuda, Noriyuki
    ONCOLOGY REPORTS, 2008, 20 (04) : 727 - 730
  • [8] Glucuronidation of SN-38, the active metabolite of irinotecan, by human hepatic microsomes
    Haaz, MC
    Rivory, L
    Jantet, S
    Ratanasavanh, D
    Robert, J
    PHARMACOLOGY & TOXICOLOGY, 1997, 80 (02): : 91 - 96
  • [9] Passage of irinotecan and its active metabolite, SN-38, into human milk
    Nakagawa, J.
    Terui, K.
    Hosoi, K.
    Ueno, K.
    Yokoyama, Y.
    Hayakari, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (05) : 579 - 582
  • [10] Uptake mechanism of irinotecan (CPT-11) and its metabolite (SN-38) by hamster intestinal cells.
    Kobayashi, K
    Bouscarel, B
    Matsuzaki, Y
    Ceryak, S
    Fromm, H
    GASTROENTEROLOGY, 1998, 114 (04) : A626 - A627